secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001654954-26-002338
Event type: earnings
Sentiment:  positive
Materiality: 0.35
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q1 revenue $2.3M, net income $32,860
----------------------------------------------------

- Revenue of approx. $2.3M, down ~$0.2M from prior year quarter.
- Net income of $32,860, an improvement of $24,324 compared to net loss in same quarter last year.
- CEO cites improved operational efficiency and disciplined cost management.
- Company focuses on sharpening service portfolio and concentrating on highest-value markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426002338/0001654954-26-002338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426002338/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-002338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer